Vonoprazan-based therapy has lower failure rate in eradicating helicobacter pylori compared to proton pump inhibitors-based therapy: A meta-analysis of randomized controlled trials
Introduction: Helicobacter pylori infection is worldwide health problems and well known as causative agent of gastric ulcer and gastric cancer. Main therapy of Helicobacter pylori infection is still Proton-pump inhibitor based therapy. However, previous studies using Vonoprazanbased therapy showed p...
Saved in:
Main Authors: | B.P. Putra, Muhammad Miftahussurur |
---|---|
Format: | Article PeerReviewed |
Language: | English |
Published: |
Yerevan State Medical University
2019
|
Subjects: | |
Online Access: | http://repository.unair.ac.id/94576/1/Miftahussurur-Vonoprazan%20based%20therapy%20has%20lower.pdf http://repository.unair.ac.id/94576/ https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077540360&partnerID=40&md5=04f76d5fac888ffedd86337f8ee5576e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universitas Airlangga |
Language: | English |
Similar Items
-
Effect of bacterial and host factors on helicobacter pylori eradication therapy
by: Takahiro Uotani, et al.
Published: (2015) -
Helicobacter pylori urease for diagnosis of helicobacter pylori infection: a mini review.
by: D.Y. Graham, et al.
Published: (2018) -
Clarithromycin-based triple therapy is still useful as an initial treatment for helicobacter pylori infection in the Dominican Republic
by: Muhammad Miftahussurur, et al.
Published: (2017) -
Population-based strategies for Helicobacter pylori-associated disease management: Asian perspective
by: Muhammad Miftahussurur, et al.
Published: (2016) -
Alternative eradication regimens for helicobacter pylori infection in indonesian regions with high metronidazole and levofloxacin resistance
by: Muhammad Miftahussurur, et al.
Published: (2019)